Motion for a resolution - B9-0475/2021Motion for a resolution
B9-0475/2021

    MOTION FOR A RESOLUTION on creating a European compensation fund for victims of the ‘COVID-19 vaccines’

    23.9.2021

    pursuant to Rule 143 of the Rules of Procedure
    - Comirnaty (Pfizer, BioNTech)
    - Janssen COVID-19 vaccine
    - Spikevax (Moderna)
    - Vaxzevria (AstraZeneca)

    Virginie Joron

    B9‑0475/2021

    Motion for a European Parliament resolution on creating a European compensation fund for victims of the ‘COVID-19 vaccines’

    The European Parliament,

     having regard to Rule 143 of its Rules of Procedure,

    A. whereas the European Medicines Agency (EMA) has already recorded around a million cases of people experiencing adverse reactions from the COVID-19 vaccines:

    - 435 779 due to the Pfizer BioNTech vaccine,

    - 373 285 due to the AstraZeneca vaccine,

    - 117 243 due to the Moderna vaccine,

    - 27 694 due to the Janssen vaccine[1];

    B. whereas these adverse reactions are sometimes severe; whereas around 75 000 people suffered from serious neurological effects as a result of taking the Pfizer vaccine;

    C. whereas the EMA states that around 5 000 people have died in the EU as a result of taking the COVID-19 vaccines:

    - 4 198 due to the Pfizer vaccine[2],

    - 1 053 due to the AstraZeneca vaccine,

    - 392 due to the Moderna vaccine,

    - 138 due to the Janssen vaccine;

    D. whereas the European Commission negotiated the purchase contracts and did not wish for the pharmaceutical companies to incur any liability;  whereas MEPs were not granted access to the contracts during the negotiations;

    1. Calls on the Commission to create a European compensation fund for victims of the COVID-19 vaccines;

    2. Instructs its President to forward this resolution to the Commission and the Member States.

    Last updated: 14 October 2021
    Legal notice - Privacy policy